As Vice President of Global Patient Safety Evaluation, Sumit works within the research and development function of Takeda Pharmaceuticals. He serves the role of European Union (EU) and United Kingdom (UK) Qualified Person responsible for Pharmacovigilance (QPPV) for the company. QPPV is a requirement for the Marketing Authorisation Holder (MAH). Sumit is also the Responsible Officer for Takeda Designated Body for General Medical Council UK registered physicians. He engages externally via industry federations and universities.